Innovative Cellular Therapeutics Holdings Ltd
- SEC CIK
- 0002095697
In the past year, 2 open-market sale filings worth $274.3 and no purchases.
Current role at each company
- LYEL Lyell Immunopharma, Inc.10% Owneras of Jul 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $274.3
- 2 filings
- Net
- −$274.3
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Innovative Cellular Therapeutics Holdings Ltd as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 (view filing)2:55 PM ET | Jul 17 | 3 days | Innovative Cellular Therapeutics Holdings Ltd10% Owner | SSale | −10 | $13.70 | −$137 | 0.0%2.86M after | 10b5-1 |
| Jul 17, 2026 (view filing)9:45 PM ET | Jul 16 | 1 day | Innovative Cellular Therapeutics Holdings Ltd10% Owner | SSale | −10 | $13.73 | −$137.3 | 0.0%2.86M after | 10b5-1 |